[Federal Register Volume 63, Number 29 (Thursday, February 12, 1998)]
[Notices]
[Page 7182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3609]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on December 9, 1997, Orpharm,
Inc., 728 West 19th Street, Houston, Texas 77008, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as a bulk manufacturer of the basic classes of controlled substances
listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methadone (9250)........................... II
Methadone-intermediate (9254).............. II
Levo-alphacetylmethadol (9648)............. II
------------------------------------------------------------------------
The firm plans manufacture methadone and methadone-intermediate for
production of LAAM.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, DC 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than April 13, 1998.
Dated: January 21, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 98-3609 Filed 2-11-98; 8:45 am]
BILLING CODE 4410-09-M